MerLion Pharma (Germany)
In research, MerLion Pharma (Germany) stands highest in Medicine (#12,681 of 17,978 worldwide) and Health Sciences (#15,740 of 20,462 worldwide), over all time.
- World rank, all time
- #15,479 of 42,892
- Rank in Germany
- #761 of 2,077
- Research works
- 287 ▼ 30% vs 2013–17
- Citations
- 11k 37.7 per fractional work
- Top-10% rate
- 17.1% record average 16.5%
- Open access
- 26% world 28%
What is MerLion Pharma (Germany) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #12,681 of 17,978 | 21.5% | 144 | |
| Health SciencesDomain | #15,740 of 20,462 | 21.5% | 148 |
Each strip is that field’s whole ranked pool, with the notch where MerLion Pharma (Germany) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 4.5×. Every wedge is a field page.
- Neuroscience 4.5×
- Medicine 3.2×
- Biochemistry, Genetics and Molecular Biology 2.7×
- Pharmacology, Toxicology and Pharmaceutics 1.9×
- Chemistry 1.8×
- Immunology and Microbiology 1.6×
- Nursing 1.3×
- Health Professions 0.4×
- Psychology 0.3×
- Social Sciences 0.3×
- Environmental Science 0.2×
- Agricultural and Biological Sciences 0.2×
- Engineering 0.1×
- Computer Science 0.1×
- Materials Science 0.1×
Who are the top researchers at MerLion Pharma (Germany)?
Ranked on the composite score, Chris G. Parsons, Angelika Hanschmann and Astrid Scheschonka lead among researchers whose main affiliation is MerLion Pharma (Germany).
- 1 Chris G. Parsons Germany · #849,319 worldwide 58 citations · 18 works
- 2 Angelika Hanschmann Germany · #1,054,549 worldwide 0 citations · 18 works
- 3 Astrid Scheschonka Germany · #1,186,667 worldwide 16 citations · 18 works
- 4 Michael Althaus Germany · #1,235,401 worldwide 12 citations · 23 works
Which keywords describe research at MerLion Pharma (Germany)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Neurological Disorders, Treatment, Stroke, Pain Management, Botulinum Toxin, Neurotoxins, Parkinson's Disease and Basal Ganglia.
- Charcot-Marie-Tooth Disease
- Rehabilitation
- Antibiotic Resistance
- Treatment-Resistant Depression
- Subthalamic Nucleus
- Monoclonal Antibodies
- Mitochondrial Dysfunction
- Parkinson's Disease
- Neurotoxins
- Pain Management
- Treatment
- Neurological Disorders
- Stroke
- Botulinum Toxin
- Epidemiology
- Basal Ganglia
- Deep Brain Stimulation
- Quality of Life
- Therapeutic Antibodies
- Glycosylation
- Genetic Mutations
- Vaccine Development
- Hereditary Spastic Paraplegia
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 23 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 23 words, with their numbers
- Neurological Disorders6▲ 41×5 topics
- Treatment5▲ 16×3 topics
- Stroke4▲ 95×3 topics
- Pain Management4▲ 74×4 topics
- Botulinum Toxin4▲ 254×1 topic
- Neurotoxins4▲ 408×1 topic
- Epidemiology3▲ 2.5×10 topics
- Parkinson's Disease2▲ 30×3 topics
- Basal Ganglia2▲ 117×2 topics
- Mitochondrial Dysfunction2▲ 20×3 topics
- Deep Brain Stimulation2▲ 85×2 topics
- Monoclonal Antibodies2▲ 63×2 topics
- Quality of Life2▲ 3.9×7 topics
- Subthalamic Nucleus2▲ 143×1 topic
- Therapeutic Antibodies2▲ 81×2 topics
- Treatment-Resistant Depression2▲ 89×1 topic
- Glycosylation1▲ 47×3 topics
- Antibiotic Resistance1▲ 13×2 topics
- Genetic Mutations1▲ 11×2 topics
- Rehabilitation1▲ 12×4 topics
- Vaccine Development1▲ 17×2 topics
- Charcot-Marie-Tooth Disease1▲ 342×1 topic
- Hereditary Spastic Paraplegia1▲ 342×1 topic
Which research topics does MerLion Pharma (Germany) publish most on?
By volume in 2022–2025: Botulinum Toxin and Related Neurological Disorders, Neurological disorders and treatments, Hereditary Neurological Disorders and Cancer Treatment and Pharmacology.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Botulinum Toxin and Related Neurological Disorders Neurology 4 works
- 2 Neurological disorders and treatments Neurology 2 works
- 3 Hereditary Neurological Disorders Cellular and Molecular Neuroscience 1 works
- 4 Cancer Treatment and Pharmacology Oncology 1 works
- 5 Burkholderia infections and melioidosis Epidemiology 1 works
- 6 Cerebral Palsy and Movement Disorders Psychiatry and Mental health 1 works
- 7 Protein purification and stability Molecular Biology 1 works
- 8 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 9 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
- 10 Stroke Rehabilitation and Recovery Rehabilitation 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has MerLion Pharma (Germany)'s research output changed?
Output in 2018–2022 was 30% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Berlin
- Freie Universität Berlin
- Technische Universität Berlin
- Humboldt-Universität zu Berlin
- Charité - Universitätsmedizin Berlin
- Fritz Haber Institute of the Max Planck Society
- Federal Institute For Materials Research and Testing
- Fraunhofer Institute for Telecommunications, Heinrich Hertz Institute
- Robert Koch Institute
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.